EMA – Open consultation: Concept paper on the need for a reflection paper on assessment of cardiovascular safety of oncology medicinal products
The EMA issued for comments a Concept paper on the need for a reflection paper on assessment of cardiovascular safety of oncology medicinal products.
The purpose of the proposed reflection paper is to provide recommendations for the planning, collection of data and evaluation of cardiovascular (CV) safety of oncology medicinal products taking into account specific issues that apply to the oncology setting with respect to type of medicinal products applied, patients and trials designs.
The deadline for the consultation is 31 October 2024.
More open consultations on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (19 octobre 2024). EMA – Open consultation: Concept paper on the need for a reflection paper on assessment of cardiovascular safety of oncology medicinal products. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/12j9u





